In the German Democratic Republic (GDR), a tightly organised vaccination system was established in the 1950s and 1960s. In this context, the medical effort to stop the spread of infectious diseases in the post-war period was coupled with the political will to present itself as a responsible preventive state. Based on unpublished archival material, we will shed light on the everyday practice of vaccination in the early GDR. We can show that the vaccination targets were difficult to achieve due to material shortages, personnel shortages and a lack of foreign currency. Often, the politically set norms had to be adapted to everyday realities and pragmatic solutions had to be found. Strategies for dealing with scarce vaccination resources included delegating vaccinations to non-medical personnel and using intradermal application to save vaccine. Vaccination fatigue in the population was also an issue for the health authorities in the GDR. To achieve high vaccination rates, the GDR Ministry of Health introduced performance comparisons at the district and county level. In addition, admission to daycare centres and holiday camps was made contingent upon the presentation of the relevant vaccination certificates. Further sanctions, such as fines, were rarely imposed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00103-025-04028-2 | DOI Listing |
Gac Sanit
March 2025
Financial Economics and Accounting Department, University of Alicante, Alicante, Spain.
Objective: To review several behavioral economics-based interventions ("healthy nudges") aimed at mitigating the overuse and underuse of healthcare resources -phenomena associated with poorer health outcomes and increased costs.
Method: A comparative case study approach is used to assess the effectiveness of ten studies designed to improve treatment adherence and prevent underuse, as well as those focused on improving prescribing practices to address overuse.
Results: First, healthy nudges are generally effective, although there is considerable variability in their outcomes.
Res Social Adm Pharm
March 2025
WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (GÖG / Austrian National Public Health Institute), Stubenring 6, 1010, Vienna, Austria; Department of Health Policy, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, UK. Electronic address:
Background: Community pharmacy appears to have undergone considerable change over the years.
Objectives: The objective of this research is to study the range of community pharmacy services provided in late stages of the COVID-19 pandemic and during the last decades and to identify potential drivers for change.
Methods: Four European countries (Austria, England, Estonia, and Portugal), which represent a balance in terms of income, organization of the health system and pharmacy services, were selected as case studies.
Vaccine
March 2025
Robert Koch Institute, Am Nordufer 20, 13353 Berlin, Germany. Electronic address:
Introduction: As of 24 October 2021, 128,868 laboratory-confirmed COVID-19 cases and 3550 deaths were reported from Namibia. The national COVID-19 vaccination campaign that started in March 2021 included health workers (HWs) as a priority group. The vaccines most administered were Sinopharm, AstraZeneca, Pfizer-BioNtech, and Janssen.
View Article and Find Full Text PDFDig Liver Dis
March 2025
Université Clermont Auvergne, Inserm, CHU Clermont-Ferrand, 3iHP, Service d'Hépato-Gastro Entérologie, Clermont-Ferrand, France; Université Clermont Auvergne, 3iHP, Inserm U1071, M2iSH, USC-INRA 2018, F-63000 Clermont-Ferrand, France. Electronic address:
J Cosmet Laser Ther
March 2025
Department of Dermatology, The University of California, San Diego, USA.
Delayed inflammatory nodules (DIN) after soft-tissue filler injection may occur after infections, vaccinations, or procedures. We report a DIN from predominantly low-molecular-weight HA (PLMW-HA) filler secondary to COVID-19 infection that was resistant to conservative management, requiring intralesional combination therapy with triamcinolone, 5-fluorouracil, and recombinant human hyaluronidase for resolution.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!